Catalyst Wire Dossier Catalyst Wire Dossier

RYTELO

imetelstat sodium · Geron Corporation
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RYTELO, covering 2024-06-06 to 2026-04-14. Get the full timeline:

Most recent: FDA Approved: RYTELO — Supplemental Application (Geron Corporation)

See pricing